Introduction: Assessment of comorbid cardiovascular disease can predict health outcomes and may risk-stratify patients for adverse events and death. Current methods used to estimate patient risk, such as the Charlson Comorbidity Index (CCI), are based on International Classification of Diseases (ICD) codes, which are a poor indicator of severity and complexity of comorbid disease. In […]
10. Cardiovascular Medications and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer
